Newsletter | June 12, 2025

06.12.25 -- Celebrating Clinical Trials Day: Making The Most Of Resources

SPONSOR

Challenging the Norm: Smaller Partners, Bigger Impact (Big is Bad Trigger)

In our outsourcing industry, it is never an easy decision to select a partner when trying to run complex sequential trials. The need to gain regulatory approval for the treatments you have dedicated yourself to providing, coupled with the need to find a capable, reliable, and fair Contract Research Organization is quite daunting. Discover how a smaller full-service partner may be better suited to see your study through.

REGULATORY & COMPLIANCE

Why Perfect Clinical Trial Data Is A Dangerous Myth

Former FDA inspector Kara Harrison reveals clinical trials fail due to overcomplex designs, checklist-driven monitoring that misses critical issues, and lack of focus on what actually matters for patient safety and data integrity.

The Regulatory Binder Checklist For Clinical Trial Sites

By following this checklist, research teams can enhance organizational efficiency, maintain compliance with regulatory standards, and confidently navigate the complexities of documentation management.

A New Approach To Generating Clinical Evidence

For rare diseases, scientific breakthroughs often stall before reaching patients. A new approach to generating clinical evidence could change that trajectory.

The Role Of FDA Initiatives In Early-Phase Oncology Trials

Project FrontRunner represents a paradigm shift in oncology drug development, championing earlier-line studies to bring novel treatments to patients sooner.

Regulatory Special Designations

Discover how securing an FDA special designation can accelerate your drug development process and bring life-saving therapies to market faster.

OUTSOURCING MODELS

Celebrating Clinical Trials Day, Part 3: Making The Most Of Resources

Celebrate Clinical Trials Day 2025 with these industry experts, who share their experiences in and advice for establishing partnerships and finding the best talent.

Improving ISR Success Rates In Bioanalysis Of Small Molecule Drugs

Leveraging incurred sample reanalysis (ISR) in your quality control helps your team mitigate risks, establish regulatory compliance, and instill confidence in your pharmacokinetic modeling.

Building Robust Clinical Supply Chains To Support Global Trials

Ensuring drugs reach patients at the right time and place is crucial. Review key areas to consider as you build a robust clinical supply chain that supports global trials effectively and efficiently.

How To Avoid Costly Study Delays And Mitigate Risks

Are you still in doubt about your study protocol or how to determine the sample size? Gain access to free clinical trial budgeting and MedSci consulting services from a leading Eastern European CRO.

Clinical Trial Services

Explore the latest trends in sustainable living and guarantee the proper handling of your clinical materials to cover everything from warehousing and distribution to returns, collection, and destruction.

Liver Disease CRO Services

Biotechnology companies consider locations in the Asia-Pacific region, such as South Korea and China to access vast treatment-naïve patient populations and accelerate their clinical trials at lower costs. 

CHOOSE YOUR OWN ADVENTURE

You're receiving the Thursday edition of the Clinical Leader newsletter, focusing on Outsourcing Models and Regulatory & Compliance. To make changes to your newsletter selections, update your topic preferences.

  • Clinical Sites | Patient Centricity | Patient Recruitment (Monday)
  • Clinical Trial Technology (Tuesday)
  • Decentralized Trials | Trial Management (Wednesday)
  • Outsourcing Models | Regulatory & Compliance (Thursday)
  • Clinical Data Management & Analytics | Trial Monitoring (Friday)

Learn more about our personalized newsletters here.

Connect With Clinical Leader: